Guggenheim Capital’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-70,606
| Closed | -$662K | – | 1956 |
|
|
2023
Q3 | $662K | Buy |
70,606
+7,455
| +12% | +$69.9K | 0.01% | 1289 |
|
|
2023
Q2 | $1.55M | Buy |
63,151
+10,777
| +21% | +$264K | 0.01% | 965 |
|
|
2023
Q1 | $1.22M | Buy |
52,374
+34,592
| +195% | +$805K | 0.01% | 1069 |
|
|
2022
Q4 | $450K | Buy |
17,782
+3,568
| +25% | +$90.3K | ﹤0.01% | 1526 |
|
|
2022
Q3 | $274K | Sell |
14,214
-15,873
| -53% | -$306K | ﹤0.01% | 1689 |
|
|
2022
Q2 | $766K | Buy |
+30,087
| New | +$766K | 0.01% | 1354 |
|